Product Details
Dolutegravir/Emtricitabine/Tenofovir Alafenamide Tablets**
Dolutegravir (Dolutegravir Sodium); Emtricitabine; Tenofovir Alafenamide Fumarate50 mg; 200 mg; 25 mg
Tablet
ROA
Oral
Applicant Name
Hetero Labs Nigeria Limited
NRN
A4-100042
Status
Active
Composition
Each tablet contains: 52.6 mg of Dolutegravir sodium (DTG), equivalent to 50 mg of Dolutegravir, 200 mg of Emtricitabine (FTC) and 28.04 mg of Tenofovir alafenamide fumarate (TAF), equivalent to 25 mg of Tenofovir alafenamide
ATC Code
Pending
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
Product Description
Tablet
Manufacturer Name
Hetero Labs Limited
Manufacturer Country
INDIA
Approval Date
2021-05-07
Expiry Date
2026-05-06